180 related articles for article (PubMed ID: 15609234)
21. Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population.
Kis A; Fehér E; Gáll T; Tar I; Boda R; Tóth ED; Méhes G; Gergely L; Szarka K
Eur J Oral Sci; 2009 Oct; 117(5):536-40. PubMed ID: 19758249
[TBL] [Abstract][Full Text] [Related]
22. Periodontitis lesions are a source of salivary cytomegalovirus and Epstein-Barr virus.
Saygun I; Kubar A; Ozdemir A; Slots J
J Periodontal Res; 2005 Apr; 40(2):187-91. PubMed ID: 15733155
[TBL] [Abstract][Full Text] [Related]
23. Detection of Epstein-Barr virus (EBV) in the oral mucosa of renal transplant patients.
Braz-Silva PH; Ortega KL; Rezende NP; Nunes FD; Magalhães MH
Diagn Cytopathol; 2006 Jan; 34(1):24-8. PubMed ID: 16355381
[TBL] [Abstract][Full Text] [Related]
24. Periodontitis lesions are the main source of salivary cytomegalovirus.
Sahin S; Saygun I; Kubar A; Slots J
Oral Microbiol Immunol; 2009 Aug; 24(4):340-2. PubMed ID: 19572898
[TBL] [Abstract][Full Text] [Related]
25. [EBV replication and therapy of oral hairy leukoplakia using acyclovir].
Näher H; Helfrich S; Hartmann M; Freese UK
Hautarzt; 1990 Dec; 41(12):680-2. PubMed ID: 1965185
[TBL] [Abstract][Full Text] [Related]
26. Absence of Epstein-Barr virus in olfactory neuroblastoma.
Wang SL; Li SH; Chen WT; Chai CY
Pathology; 2007 Dec; 39(6):565-6. PubMed ID: 18027259
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation.
Walling DM; Ray AJ; Nichols JE; Flaitz CM; Nichols CM
J Virol; 2007 Jul; 81(13):7249-68. PubMed ID: 17376908
[TBL] [Abstract][Full Text] [Related]
28. Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression.
Bergallo M; Costa C; Baro S; Musso T; Balbo L; Merlino C; Cavallo R
J Biotechnol; 2007 Feb; 128(3):462-76. PubMed ID: 17147963
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients.
Suh N; Liapis H; Misdraji J; Brunt EM; Wang HL
Am J Surg Pathol; 2007 Sep; 31(9):1403-9. PubMed ID: 17721196
[TBL] [Abstract][Full Text] [Related]
30. Infection of immortalized human epithelial cell line Hacat with high-concentration Epstein-Barr virus.
Jiang PZ; Shen XM; Huang H; Yao KT
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):970-3. PubMed ID: 12433619
[TBL] [Abstract][Full Text] [Related]
31. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
32. Primary lymphoepithelioma-like carcinoma of minor salivary gland: a case report with immunohistochemical and in situ hybridization studies.
Lu SY; Huang CC; Hsiung CY; Eng HL; Huang HY
Head Neck; 2006 Feb; 28(2):182-6. PubMed ID: 16240326
[TBL] [Abstract][Full Text] [Related]
33. Extranodal malignant lymphoma of the upper aerodigestive tract: prevalence of Epstien-Barr virus (EBV) infection in King Chulalongkorn Memorial Hospital.
Assanasen T; Wannakrairot P; Keelawat S; Ruangvejvorachai P; Pramprayoon N
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S266-73. PubMed ID: 16623040
[TBL] [Abstract][Full Text] [Related]
34. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
[TBL] [Abstract][Full Text] [Related]
35. The secretory cells of mouse salivary glands are nonpermissive for polyomavirus replication.
Atencio IA; Meraz A; Villarreal LP
Virology; 1994 May; 200(2):842-8. PubMed ID: 8178470
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus in oral diseases.
Slots J; Saygun I; Sabeti M; Kubar A
J Periodontal Res; 2006 Aug; 41(4):235-44. PubMed ID: 16827715
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus infections: prospects for treatment.
Gershburg E; Pagano JS
J Antimicrob Chemother; 2005 Aug; 56(2):277-81. PubMed ID: 16006448
[TBL] [Abstract][Full Text] [Related]
38. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus (EBV) infection and p53 protein expression in gastric carcinoma.
Szkaradkiewicz A; Majewski W; Wal M; Czyzak M; Majewski P; Bierła J; Kuch A
Virus Res; 2006 Jun; 118(1-2):115-9. PubMed ID: 16413625
[TBL] [Abstract][Full Text] [Related]
40. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
